Table 2:

CBF and metabolite ratios from different regions of gliomas

Glioma RegionLow Grade
CBFG/WMNAAG/WMCrG/WMChoG/WMmInsWMGlxG/WMLip+LacG/CrWM
Hyperperfused1.73 ± 0.620.51 ± 0.110.74 ± 0.171.15 ± 0.311.16 ± 0.310.63 ± 0.212.23 ± 0.65
Hypoperfused0.79 ± 0.090.62 ± 0.270.96 ± 0.341.41 ± 0.571.20 ± 0.520.60 ± 0.122.20 ± 0.63
Isoperfused0.93 ± 0.090.56 ± 0.120.89 ± 0.261.49 ± 0.151.18 ± 0.380.68 ± 0.241.44 ± 0.59
High Grade
Hyperperfused1.94 ± 0.470.46 ± 0.170.73 ± 0.272.11 ± 0.46*1.39 ± 0.551.01 ± 0.52*6.83 ± 4.17*
Hypoperfused0.87 ± 0.070.46 ± 0.070.70 ± 0.201.55 ± 0.41.18 ± 0.430.78 ± 0.142.87 ± 1.13
Isoperfused0.98 ± 0.10.40 ± 200.71 ± 0.191.71 ± 0.591.42 ± 0.730.71 ± 0.122.21 ± 1.05
  • Note:—CBF indicates cerebral blood flow; G/WM, glioma/white matter; Cr, creatine; Cho, choline; mIns, myo-inositol; Glx, glutamine/glutamate; Lip+Lac, lipid and lactate.

  • * Significantly higher (P < .05) compared with low-grade glioma.